PharmAthene slides on FDA hold for anthrax vaccine

PharmAthene Inc. (NYSE-M:PIP) fell $0.19 (13%) to $1.27 on Friday after FDA placed the company's SparVax anthrax vaccine program on clinical hold. PharmAthene expects to receive a letter within 30 day...